Diastolic function as an early marker for systolic dysfunction and all-cause mortality among cancer patients.

Joshua H ArnoldZach RozenbaumAviram HochstadtRoni RosenChen SherezAyelet SivanLiat MorYonatan MoshkovitsBen SadehOfer HavakukAssi MilwidskySivan ShamaiSvetlana Sirota DorfmanYaron ArbelYan TopilskyMichal Laufer-Perl

Published in: Echocardiography (Mount Kisco, N.Y.) (2021)

Among active cancer patients, evaluation of diastolic function may provide an early marker for the development of systolic dysfunction, as well as all-cause mortality.

Keyphrases

left ventricular
blood pressure
heart failure
oxidative stress
ejection fraction